Evidence map›Paper›PMID 41287095›Full record

ArticleJournal of medical case reports2025

Combined retinal vein occlusion and retinal artery occlusion in a patient undergoing therapy for metastatic breast cancer: a case report.

Mariaelena Malvasi, Giovanni Bellisario, Giacomo Panozzo

Erratum issuedAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Mariaelena MalvasiDepartment of Sense Organs, Faculty of Medicine and Dentistry, Sapienza University of Rome, P.Le A. Moro 5, 00185, Rome, Italy. mariaelena.malvasi@uniroma1.it.
Giovanni BellisarioOphthalmology Unit, Department of Neurosciences, Biomedicine and Movement, University of Verona, Verona, Italy.
Giacomo PanozzoOphthalmology Unit, Clinica San Francesco, Verona, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis case involves a patient on aromatase inhibitor therapy for breast carcinoma who experienced combined retinal artery and vein occlusion. CASE PRESENTATION: A 56-year-old Caucasian woman of northern Italian origin, who was initially diagnosed with central vein occlusion in the left eye treated with ranibizumab and laser photocoagulation, later experienced a new episode of visual decrease in the same eye secondary to retinal artery occlusion. These vascular occlusions followed a diagnosis of stage G2 infiltrating ductal breast cancer, for which she was receiving systemic therapy with tamoxifen and letrozole.

conclusionThis case report highlights the factors associated with retinal occlusion during aromatase inhibitor treatment for breast cancer, aiming to prevent ocular adverse events and visual deterioration, and underscoring the importance of ophthalmic screening for early diagnosis and appropriate treatment, as visual disturbances may be underestimated owing to the systemic pathology.

Indexed as

Aromatase InhibitorsBreast NeoplasmsCarcinoma, Ductal, BreastRetinal Artery OcclusionRetinal Vein OcclusionFemaleHumansLetrozoleMiddle AgedNitrilesTamoxifenTriazolesAromatase InhibitorsLetrozoleNitrilesTamoxifenTriazolesBreast cancerLetrozoleRetinal artery occlusionRetinal vein occlusionTamoxifen

Identifiers

PMID41287095
PMCPMC12642219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.